Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Ta, Bogush"'
Publikováno v:
Europe PubMed Central
The review is concerned with the crucial marker of nucleotide excision repair ERCC1 and its contribution to platinum resistance of ovarian cancer. All the variants of the laboratory and clinical ERCC1 assessment in the ovarian cancer tissue (single n
Autor:
Ta, Bogush, Av, Konukhova, Ab, Ravcheeva, Tn, Zabotina, Z.G. Kadagidze, Ea, Bogush, Dv, Komov, Be, Polotskiĭ, Kk, Laktionov, Mi, Davydov
Publikováno v:
Europe PubMed Central
With an account of the literature data that platinum drugs react with many cellular targets, including ATP and proteins, the authors suggested that disturbance of the function of energy-dependent ABC-transporters (markers of multidrug resistance, MDR
Autor:
Scherbakov AM; Department of Experimental Tumor Biology, Blokhin N.N. National Medical Research Center of Oncology, Moscow 115522, Russian Federation., Basharina AA; Group of Molecular Tumor Markers, Blokhin N.N. National Medical Research Center of Oncology, Moscow 115522, Russian Federation., Sorokin DV; Department of Experimental Tumor Biology, Blokhin N.N. National Medical Research Center of Oncology, Moscow 115522, Russian Federation., Mikhaevich EI; Department of Experimental Tumor Biology, Blokhin N.N. National Medical Research Center of Oncology, Moscow 115522, Russian Federation., Mizaeva IE; Group of Molecular Tumor Markers, Blokhin N.N. National Medical Research Center of Oncology, Moscow 115522, Russian Federation., Mikhaylova AL; Department of Experimental Tumor Biology, Blokhin N.N. National Medical Research Center of Oncology, Moscow 115522, Russian Federation., Bogush TA; Group of Molecular Tumor Markers, Blokhin N.N. National Medical Research Center of Oncology, Moscow 115522, Russian Federation., Krasil'nikov MA; Department of Experimental Tumor Biology, Blokhin N.N. National Medical Research Center of Oncology, Moscow 115522, Russian Federation.
Publikováno v:
Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2023 Feb 07; Vol. 6 (1), pp. 103-115. Date of Electronic Publication: 2023 Feb 07 (Print Publication: 2023).
Autor:
Bogush TA; Group of Molecular Tumor Markers, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Basharina AA; Group of Molecular Tumor Markers, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russian Federation., Bogush EA; Department of Oncology, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation., Scherbakov AM; Laboratory of Oncoproteomics, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russian Federation. alex.scherbakov@gmail.com., Davydov MM; Department of Oncology, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation., Kosorukov VS; Laboratory of Transgenic Drugs, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Publikováno v:
Irish journal of medical science [Ir J Med Sci] 2022 Oct; Vol. 191 (5), pp. 2047-2053. Date of Electronic Publication: 2021 Nov 06.
Autor:
Bogush TA; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia.; tatbogush@mail.ru., Basharina AA; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Safarov ZM; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Mizaeva IE; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Grishanina AN; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Bogush EA; Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, 119991 Russia., Gridneva YV; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Volkova MI; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Matveev VB; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Kosorukov VS; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, 115478 Russia.
Publikováno v:
Molekuliarnaia biologiia [Mol Biol (Mosk)] 2022 Jul-Aug; Vol. 56 (4), pp. 642-651.
Autor:
Apanovich NV; N. P. Bochkov Research Centre for Medical Genetics, Moscow, Russia., Apanovich PV; N. P. Bochkov Research Centre for Medical Genetics, Moscow, Russia., Mansorunov DJ; N. P. Bochkov Research Centre for Medical Genetics, Moscow, Russia., Kuzevanova AY; N. P. Bochkov Research Centre for Medical Genetics, Moscow, Russia., Korotaeva AA; N. P. Bochkov Research Centre for Medical Genetics, Moscow, Russia., Bogush TA; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Matveev VB; N. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Moscow, Russia., Karpukhin AV; N. P. Bochkov Research Centre for Medical Genetics, Moscow, Russia. karpukhin@med-gen.ru.
Publikováno v:
Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2022 Apr; Vol. 172 (6), pp. 738-742. Date of Electronic Publication: 2022 May 02.
Autor:
Bogush TA; Department of Tumor Molecular Markers, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 24 Kashirskoe Shosse, Moscow, Russia., Basharina AA; Department of Tumor Molecular Markers, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 24 Kashirskoe Shosse, Moscow, Russia., Eliseeva BK; Department of Tumor Molecular Markers, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 24 Kashirskoe Shosse, Moscow, Russia., Kaliuzhny SA; Department of Tumor Molecular Markers, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 24 Kashirskoe Shosse, Moscow, Russia., Bogush EA; Oncological Department of Surgery no. 2, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 23 Kashirskoe Shosse, Moscow, Russia.; Department of Oncology, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya str., Moscow, Russia., Kirsanov VY; Department of Oncology, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya str., Moscow, Russia., Davydov MM; Department of Oncology, N.V. Sklifosovsky Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8-2 Trubetskaya str., Moscow, Russia., Kosorukov VS; Laboratory of Transgenic Drugs, N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, 24 Kashirskoe Shosse, Moscow, Russia.
Publikováno v:
BioTechniques [Biotechniques] 2020 Oct; Vol. 69 (4), pp. 257-263. Date of Electronic Publication: 2020 Aug 11.
Autor:
Scherbakov AM; Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Shestakova EA; Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, 115478 Russia.; elenaanshestakova@mail.ru., Galeeva KE; Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, 115478 Russia., Bogush TA; Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, 115478 Russia.
Publikováno v:
Molekuliarnaia biologiia [Mol Biol (Mosk)] 2019 May-Jun; Vol. 53 (3), pp. 502-512.
Autor:
Bogush TA; Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia. tatbogush@mail.ru., Basharina AA; Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia.; Faculty of Fundamental Medicine, Moscow State University, Moscow, 119192, Russia., Bogush EA; Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Ryabinina OM; Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Tjulandina AS; Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Tjulandin SA; Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia.
Publikováno v:
Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2018 Sep; Vol. 482 (1), pp. 249-251. Date of Electronic Publication: 2018 Nov 05.
Autor:
Bogush TA; a N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Research Institute of Experimental Diagnostics and Tumor Therapy , Kashirskoe shosse 24, Moscow , Russia., Polezhaev BB; b Faculty of Fundamental Medicine, M. V. Lomonosov Moscow State University , Department of General Medicine , Leninskie Gory, Moscow , Russian Federation., Mamichev IA; a N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Research Institute of Experimental Diagnostics and Tumor Therapy , Kashirskoe shosse 24, Moscow , Russia., Bogush EA; a N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Research Institute of Experimental Diagnostics and Tumor Therapy , Kashirskoe shosse 24, Moscow , Russia., Polotsky BE; a N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Research Institute of Experimental Diagnostics and Tumor Therapy , Kashirskoe shosse 24, Moscow , Russia., Tjulandin SA; a N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Research Institute of Experimental Diagnostics and Tumor Therapy , Kashirskoe shosse 24, Moscow , Russia., Ryabov AB; c N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation , Research Institute of Pediatric Oncology and Hematology , Kashirskoe shosse 24, Moscow , Russia.
Publikováno v:
Cancer investigation [Cancer Invest] 2018 Apr 21; Vol. 36 (4), pp. 211-220. Date of Electronic Publication: 2018 May 04.